209 related articles for article (PubMed ID: 34807928)
1. Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis.
Wang T; Fei J; Nie S
PLoS One; 2021; 16(11):e0260035. PubMed ID: 34807928
[TBL] [Abstract][Full Text] [Related]
2. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis.
Shi W; Feng W; Wang J; Zhai C; Zhang Q; Wang Q; Song Y; Yan X; Chai L; Liu P; Chen Y; Li C; Li M
J Cancer; 2019; 10(23):5754-5763. PubMed ID: 31737112
[No Abstract] [Full Text] [Related]
4. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological significance of Golgi phosphoprotein 3 expression in papillary thyroid carcinoma].
Huang DH; Jin L; Xie WW; Lin Q; Chen X
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2831-2835. PubMed ID: 31550811
[No Abstract] [Full Text] [Related]
6. Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: a systematic review and meta-analysis.
Li Y; Wu G; Zhang Y; Han B; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Fan D; Hong L
BMC Cancer; 2022 Mar; 22(1):290. PubMed ID: 35303818
[TBL] [Abstract][Full Text] [Related]
7. Golgi phosphoprotein3 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
Jiang Y; Su Y; Zhao Y; Pan C; Chen L
Int J Clin Exp Pathol; 2015; 8(9):10615-24. PubMed ID: 26617771
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis.
Wang S; Yuan B; Wang Y; Li M; Liu X; Cao J; Li C; Hu J
Int J Colorectal Dis; 2021 Jan; 36(1):117-130. PubMed ID: 32910207
[TBL] [Abstract][Full Text] [Related]
9. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of long non-coding RNA UCA1 in colorectal cancer: Results from a meta-analysis.
Liu X; Liu X; Qiao T; Chen W
Medicine (Baltimore); 2019 Nov; 98(48):e18031. PubMed ID: 31770217
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer.
Hua X; Yu L; Pan W; Huang X; Liao Z; Xian Q; Fang L; Shen H
Diagn Pathol; 2012 Sep; 7():127. PubMed ID: 23006319
[TBL] [Abstract][Full Text] [Related]
12. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
Zhang L; Guo F; Gao X; Wu Y
Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
14. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma.
Hu GS; Li YQ; Yang YM; Shi W; Liao AJ; Yao YH; Zeng B; Yuan J
Tumour Biol; 2014 Sep; 35(9):8625-32. PubMed ID: 24867097
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.
Zhang LJ; Wang KB; Liu LS; Chen LZ; Peng BG; Liang LJ; Li Z; Xue L; Li W; Xia JT
BMC Cancer; 2014 Aug; 14():571. PubMed ID: 25104140
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.
Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N
Gene; 2019 Dec; 721():144097. PubMed ID: 31493507
[TBL] [Abstract][Full Text] [Related]
17. Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer.
Guo YT; Qiu CZ; Huang ZX; Yu WS; Yang XF; Wang MZ
World J Gastroenterol; 2015 Dec; 21(48):13473-9. PubMed ID: 26730158
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 Overexpression on Tumor-Infiltrating Lymphocytes Related to Better Prognosis of Colorectal Cancer.
Wang JL; Yu T; Sun TT; Feng Y; Xiong H; Fang JY
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337839
[TBL] [Abstract][Full Text] [Related]
19. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
Li C; He X; Zhang L; Li L; Zhao W
BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]